Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » Advocacy » Advancing VHL Care: Clinicians Unite for a Multidisciplinary Approach

Advancing VHL Care: Clinicians Unite for a Multidisciplinary Approach

  • March 15, 2025

On Saturday 15 March a workshop was organised by MSD for clinicians “Advances in VHL: Multidisciplinary Forum”.

Dr Minmin Li was the facilitator for the event which had over 30 specialists and nurses from all over Australia attend. Dr Li opened with a presentation “Understanding VHL” which gave comprehensive information to the attendees. Lana, a VHL patients then told her story which really touched everyone with her honesty and candour of the impact of VHL – the troll of a disease which has affected her and her father. Dr Simon Wood (Urologist) spoke about the current management of VHL – Renal Cell Carcinoma. Then Dr Erica Jacobson (Neurosurgeon) presented current management of VHL – CNS Haemangioblastomas. Dr Othon Iliopoulos (Oncologist in Boston) joined the event virtually and spoke about HIF-2a Inhibitors: Examining the Clinical Data for VHL- Associated tumours.

There we several panel discussions and case studies during the day which included on the panels A/Prof Kathy Tucker, Dr Cathy Kiraly-Borri (Clinical Geneticist), Dr Wood, Dr Jacobson and Meredith Cummins (NECA CEO). In the afternoon there was a Fireside Chat : Navigating VHL disease, a caregivers journey with Pat & Nicky parents of Levi (VHL patient) and interviewing done by Meredith Cummins. To finish the afternoon attendees went into breakout groups, which were extremely interactive to brainstorm the goals of VHL care in each state and how could this be achieved – each group were asked to have a Wishlist – there were general consensus that there needs to be nurse coordinators in each state, development of VHL Optimal Care Pathway nationally, a resource library housed on NECA’s website for information accessible by HCPs and also patients / families – the final wish was to have a national case discussion so care could be truly multidisciplinary and improved outcomes for patients.

 

Share this post

Recent posts

BioPharmaDispatch 2025: Putting NETs on the National Agenda

May 27, 2025

WA Cancer Forum

May 27, 2025

ANZSNM 55th annual conference in Melbourne – Australia

May 27, 2025

NECA Strategy Day 2025

May 27, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousLynda Dunstone Featured in National Media on Nuclear Medicine Access
NextBunbury Support Group raises awareness of March4NETsNext

Related Posts

WA Cancer Forum

The Cancer Network WA, in collaboration with the WA Clinical Oncology Group at Cancer Council WA,  held its second annual one-day symposium “Cancer Network Forum

ANZSNM 55th annual conference in Melbourne – Australia

Thank you to Simone Leyden AM, Director Global Patient Advocacy and Government Affairs at Telix Pharmaceuticals Limited ARCS Australia, for organising sponsorship for a group

NECA Strategy Day 2025

On Wednesday 21 May, NeuroEndocrine Cancer Australia (NECA) hosted our annual Strategy Day in Sydney. It’s the one day each year when our entire team

NET Patient Chris, from Ballarat, Raises Awareness of Neuroendocrine Cancer

NeuroEndocrine Cancer Australia (NECA) is proud to recognise the advocacy efforts of NET patient Chris Geljon, who has taken the time to raise awareness of

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin